The national manufacturers of the Republic of Kazakhstan in resolving problems of production of anti-tuberculosis pharmaceuticals

2016

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.18821/0869-2106-2016-22-3-139-141
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The article presents the possibilities of national manufacturers of pharmaceuticals to provide with medicines patients with tuberculosis in the Republic of Kazakhstan